Novo said last week that CagriSema was "well-tolerated" and that the most common adverse effects were gastrointestinal, but they were "mild to moderate and diminished over time." "Investors are looking for treatment options that are best in class and will secure Novo's place in the obesity drug market," Soren Lontoft, pharma equity analyst at Sydbank, told CNBC over the phone Tuesday
Constipation affects roughly half of new Ozempic patients
The combination of cilofexor and firsocostat achieved a significant decrease in the ML NASH CRN fibrosis score (p = 0.040) and a change in biopsy area from F3-F4 fibrosis patterns to F2
IV Therapy in Palm Beach Gardens IV therapy delivers nutrients, hydration, vitamins, and antioxidants directly into the body for 100% cellular absorption, making it highly effective for boosting energy, recovery, immunity, and overall wellness
Researchers also floated broader hormonal and immune effects as possible secondary factors, though they see weight loss as the likelier explanation